Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.51EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XATEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XATEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.62EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.13.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDLEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used